Matteo Mucci

Via Polacchi 13
Chieti, 66100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Development and application of a multimatrix LC-MS/MS method for quantifying elexacaftor-tezacaftor-ivacaftor: Expanding therapeutic drug monitoring in cystic fibrosis from systemic circulation to airways and sweat.

Development and application of a multimatrix LC-MS/MS method for quantifying elexacaftor-tezacaftor-ivacaftor: Expanding therapeutic drug monitoring in cystic fibrosis from systemic circulation to airways and sweat.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 28, 2025

Inflammation and epithelial-mesenchymal transition in a CFTR-depleted human bronchial epithelial cell line revealed by proteomics and human organ-on-a-chip.

Inflammation and epithelial-mesenchymal transition in a CFTR-depleted human bronchial epithelial cell line revealed by proteomics and human organ-on-a-chip.

Journal: The FEBS journal

Published: August 29, 2024

Immunoregulatory mechanisms of the arachidonic acid pathway in cancer.

Immunoregulatory mechanisms of the arachidonic acid pathway in cancer.

Journal: FEBS letters

Published: August 01, 2024

Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy.

Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy.

Journal: Frontiers in medicine

Published: August 08, 2023

Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients.

Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients.

Journal: Cancers

Published: March 27, 2023

Specialized pro-resolving lipid mediators and resolution of viral diseases.

Specialized pro-resolving lipid mediators and resolution of viral diseases.

Journal: Prostaglandins & other lipid mediators

Published: March 15, 2023

Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples.

Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples.

Journal: Journal of visualized experiments : JoVE

Published: February 22, 2023

Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice.

Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice.

Journal: Haematologica

Published: December 20, 2022

Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro.

Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro.

Journal: Frontiers in pharmacology

Published: October 14, 2022

The specific deletion of cyclooxygenase-1 in megakaryocytes/platelets reduces intestinal polyposis in ApcMin/+ mice.

The specific deletion of cyclooxygenase-1 in megakaryocytes/platelets reduces intestinal polyposis in ApcMin/+ mice.

Journal: Pharmacological research

Published: August 02, 2022

Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies.

Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies.

Journal: Frontiers in pharmacology

Published: December 17, 2021

Characterization of cyclooxygenase-2 acetylation and prostanoid inhibition by aspirin in cellular systems.

Characterization of cyclooxygenase-2 acetylation and prostanoid inhibition by aspirin in cellular systems.

Journal: Biochemical pharmacology

Published: April 16, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026